Mexico Hemorrhoids Treatment Market, By Type (External Hemorrhoids, Internal Hemorrhoids, and Prolapsed Hemorrhoids), Treatment (Medication, Surgical Treatment, and Non-Surgical Treatment), Route of Administration (Oral, Topical, and Others), Dosage Form (Tablets, Capsules, Suppositories, Creams, Ointments, Syrup, Powder, and Others), Product Type (Over-the-Counter (OTC) and Prescription Drugs), Age (Adult, Geriatric, and Child), Distribution Channel (Store Based Retail and Online Based Retail) – Industry Trends and Forecast to 2030.
Mexico Hemorrhoids Treatment Market Analysis and Size
Due to an increase of pressure in the hemorrhoidal venous plexus, such as straining during bowel movements secondary to constipation and other factors such as obesity, pregnancy, chronic diarrhea, cirrhosis with ascites, pelvic floor dysfunction, and a low-fiber diet are major causing factors of hemorrhoids. Thousands of people in Mexico are suffering from hemorrhoids that generate a significant burden.
Data Bridge Market Research analyses that the Mexico hemorrhoids treatment market which was USD 102.67 million in 2022, is expected to reach USD 171.56 million by 2030, and is expected to undergo a CAGR of 6.9% during the forecast period 2023-2030. This indicates that the market value. “Store Based Retail” dominates the distribution channel segment due to increased interaction with certified prescribers and health professionals for use of anti-depressant and guaranteed payment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Mexico Hemorrhoids Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (External Hemorrhoids, Internal Hemorrhoids, and Prolapsed Hemorrhoids), Treatment (Medication, Surgical Treatment, and Non-Surgical Treatment), Route of Administration (Oral, Topical, and Others), Dosage Form (Tablets, Capsules, Suppositories, Creams, Ointments, Syrup, Powder, and Others), Product Type (Over-the-Counter (OTC) and Prescription Drugs), Age (Adult, Geriatric, and Child), Distribution Channel (Store Based Retail and Online Based Retail)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Teva Pharmaceutical Industries Ltd.( Israel), GENOMMA LAB ( Mexico), GlaxoSmithKline plc (U.K.), Abbott (U.S.), AbbVie Inc. (U.S.), Perrigo Company plc (Ireland), Sanofi (France), Bayer AG (Germany), CHINOIN (Hungary), Fresenius SE & Co. KGaA ( Germany), Medtronic (Ireland), Novartis AG (Switzerland), Pfizer Inc.(U.S.), Procter & Gamble (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Hemorrhoid is the anastomosis between the superior rectal artery and the superior, middle, and inferior rectal vein that surround the distal rectum and anal canal. It is a distal displacement and venous distention of the hemorrhoid cushions. First-line conservative treatment of hemorrhoids consists of a high-fiber diet (25 to 35 g per day), fiber supplementation, increased water intake, warm water (sitz) baths, and stool softeners. There are multiple topical over-the-counter hemorrhoid remedies. These may provide temporary relief, but most have not been studied for effectiveness or safety for long-term use. Prescription therapies may also be part of first-line treatment such as topical nitroglycerin. Office-based and surgical procedures can effectively treat hemorrhoids refractory to medical therapies. In general, the lower the grade, the more likely an office-based procedure will be successful, whereas recurring and grade III or IV hemorrhoids are more amenable to excisional hemorrhoidectomy.
Mexico Hemorrhoids Treatment Market Dynamics
Drivers
- Increasing Prevalence of Hemorrhoids
The prevalence of hemorrhoids is a significant driver for the market. An increase in the number of people suffering from hemorrhoids, possibly due to lifestyle factors like sedentary behaviour, obesity, and dietary habits, can drive the demand for treatments.
- Rising Number of Geriatric Population
Hemorrhoids are more common among older individuals. As the population ages, there is a potential increase in the demand for hemorrhoid treatments as this population is more prone to heart diseases. The number of persons above 65 years is projected to double in the coming years. The old age people are prone to various chronic diseases such as cardiovascular diseases, which can foster the demand for hemorrhoids treatment across the globe.
According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.
- Increasing Investment for Healthcare Infrastructure
Another significant factor influencing the growth rate of Mexico hemorrhoids treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Furthermore, rising initiatives by public and private organizations will expand the Mexico hemorrhoids treatment market. Additionally, high disposable income and sedentary lifestyle of people will result in the expansion of the Mexico hemorrhoids treatment market. Along with this, rising geriatric population and surge in thrombotic events will enhance the market's growth rate.
Opportunity
- Increase in the Number of Research and Development Activities
Rising clinical trials and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Moreover, the market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Mexico hemorrhoids treatment market growth. The rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the market during the forecast period 2023-2030.
Restraint/Challenge
- High Cost of Treatment
On the other hand, high cost of treatment will obstruct the expansion significantly. The traditional way of thinking and the embarrassment associated with seeking medical attention may further impede market expansion. These are the factors expected to obstruct the Mexico hemorrhoids treatment market growth. Moreover, the developing economies' lack of medical knowledge and information would further have projected to challenge the Mexico hemorrhoids treatment market in the forecast period 2023-2030.
This Mexico hemorrhoids treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Mexico hemorrhoids treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2022, Teva Pharmaceutical Industries Ltd., announced the acquisition of Representaciones e Investigaciones Médicas, S.A. de C.V. (“Rimsa”), a pharmaceutical manufacturing and distribution company in Mexico, for USD 2300 million, in a cash free, debt free set of transactions. The company financed the transaction using cash on hand. This has increased the presence of the company in Mexico and will generate the revenue for the company
Mexico Hemorrhoids Treatment Market Scope
The Mexico hemorrhoids treatment market is segmented on the basis of type, treatment, route of administration, dosage form, product type, age and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- External Hemorrhoids
- Internal Hemorrhoids
- Prolapsed Hemorrhoids
Treatment
- Medication
- Surgical Treatment
- Non-Surgical Treatment
Route of Administration
- Oral
- Tablets
- Capsules
- Others
- Topical
- Others
Dosage Form
- Tablets
- Capsules
- Suppositories
- Creams
- Ointments
- Syrup
- Powder
- Others
Product Type
- Over-the-Counter (OTC)
- Prescription Drugs
Age
- Adult
- Geriatric
- Child
Distribution Channel
- Store Based Retail
- Online Based Retail
Mexico Hemorrhoids Treatment Market Regional Analysis/Insights
The Mexico hemorrhoids treatment market is analysed and market size insights and trends are provided by country, type, treatment, route of administration, dosage form, product type, age and distribution channel as referenced above.
The countries covered in the Mexico hemorrhoids treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates as well as expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to the strong presence of sophisticated medical infrastructure, supportive government initiatives levels associated with comparatively higher health expenditure levels in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Mexico hemorrhoids treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Mexico hemorrhoids treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Mexico hemorrhoids treatment market. The data is available for historic period 2015-2020.
Competitive Landscape and Mexico Hemorrhoids Treatment Market Share Analysis
The Mexico hemorrhoids treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Mexico hemorrhoids treatment market .
Some of the major players operating in the Mexico hemorrhoids treatment market are:
- Teva Pharmaceutical Industries Ltd. (Israel)
- GENOMMA LAB (Mexico)
- GlaxoSmithKline plc (U.K.)
- Abbott (U.S.)
- AbbVie Inc. (U.S.)
- Perrigo Company plc (Ireland)
- Sanofi (France)
- Bayer AG (Germany)
- CHINOIN (Hungary
- Fresenius SE & Co. KGaA (Germany)
- Medtronic (Ireland)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Procter & Gamble (U.S.)
SKU-